Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s00345-020-03251-7 http://scihub22266oqcxt.onion/10.1007/s00345-020-03251-7 32417996!7229701!32417996     free     free     free       World+J+Urol 2021 ; 39 (3): 823-827 Nephropedia Template TP {{tp|p=32417996|t=2021. BCG versus COVID-19: impact on urology |pdf=|usr=}}{{32417996}} gab.com Text BCG versus COVID-19: impact on urology JO: World J Urol http://www.kidney.de/pget.php?&tw=1&pmid=32417996 #FOAvip PURPOSE: To search for evidence base for using BCG in the fight against COVID-19 and the possible impact of these clinical trials on urology practice. METHODS: A literature review about the basis of the ongoing clinical trials using BCG against COVID-19, as well as the use of BCG in urology and if there are any implications of these trials on our practice. RESULTS: Based on data from some epidemiological studies, there are some current clinical trials on the use BCG as a possible prophylactic vaccine against SARS CoV-2 which can affect urology practice. Urologists are already struggling with the global shortage of BCG which can be even more aggravated by such trials. In addition, if the ongoing trials proved the efficacy of BCG as a prophylaxis against COVID-19, this may open the door to more urological research opportunities to question the possibility that intra-vesical BCG, given its systemic immunologic effect, may have been protective to this subgroup of urological patients. CONCLUSION: The ongoing clinical trials using BCG against COVID-19 can affect our urology practice. We need to stay vigilant to such impacts: BCG shortage and possible new chances for urology research work. Twit Text FOAVip BCG versus COVID-19: impact on urology ????World J Urol http://www.kidney.de/pget.php?&tw=1&pmid=32417996 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32417996 #FOAvip English Wikipedia <ref>{{Cite pmid|32417996}}</ref> BCG versus COVID-19: impact on urology #MMPMID32417996 Desouky E World J Urol 2021[Mar]; 39 (3): 823-827 PMID32417996show ga PURPOSE: To search for evidence base for using BCG in the fight against COVID-19 and the possible impact of these clinical trials on urology practice. METHODS: A literature review about the basis of the ongoing clinical trials using BCG against COVID-19, as well as the use of BCG in urology and if there are any implications of these trials on our practice. RESULTS: Based on data from some epidemiological studies, there are some current clinical trials on the use BCG as a possible prophylactic vaccine against SARS CoV-2 which can affect urology practice. Urologists are already struggling with the global shortage of BCG which can be even more aggravated by such trials. In addition, if the ongoing trials proved the efficacy of BCG as a prophylaxis against COVID-19, this may open the door to more urological research opportunities to question the possibility that intra-vesical BCG, given its systemic immunologic effect, may have been protective to this subgroup of urological patients. CONCLUSION: The ongoing clinical trials using BCG against COVID-19 can affect our urology practice. We need to stay vigilant to such impacts: BCG shortage and possible new chances for urology research work. |Adjuvants, Immunologic/supply & distribution/*therapeutic use[MESH] |Administration, Intravesical[MESH] |BCG Vaccine/supply & distribution/*therapeutic use[MESH] |COVID-19/*prevention & control[MESH] |Carcinoma, Transitional Cell/*drug therapy[MESH] |Clinical Trials as Topic[MESH] |Humans[MESH] |SARS-CoV-2[MESH] |Urinary Bladder Neoplasms/*drug therapy[MESH]BCG versus COVID-19: impact on urology (epmc).pdf DeepDyve Pubget Overpricing